DXR
Daxor·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 0
Bullish Abandoned Baby
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About DXR
Daxor Corporation
The global leader in blood volume measurement technology
Healthcare Equipment and Supplies
--
02/02/2022
NASDAQ Stock Exchange
37
12-31
Common stock
109 Meco Lane, Oak Ridge, TN 37830
--
Daxor Corporation is a medical device manufacturing company that provides additional biotechnology services such as sperm refrigeration and blood refrigeration through its wholly-owned subsidiary Scientific Medical Systems Inc. The company is committed to developing and selling the BVA 100 blood volume analyzer, a tool that can quickly and accurately measure human blood volume. The company was originally established in New York as a medical instrument company in May 1971 to provide sperm refrigeration services and continues to provide these services through its wholly-owned subsidiaries. In October 1971, the medical device company changed its name to Idant Corporation. In May 1973, Idant Corporation changed its name to Daxor Corporation.
Company Financials
EPS
DXR has released its 2011 Q4 earnings. EPS was reported at -0.35, versus the expected 0, missing expectations. The chart below visualizes how DXR has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
